Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

IDX/PRDA stock hub

IDX/PRDA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IDX/PRDAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3T
Indonesia Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
IDX/PRDA
In the news

Latest news · IDX/PRDA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.8
P25 9.4P50 14.4P75 23.9
Trailing P/E10.5
P25 11.5P50 23.8P75 52.6
ROE8.8
P25 0.6P50 5.1P75 12.2
ROIC11.4
P25 1.3P50 6P75 11.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IDX/PRDA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
234
Groups with data
11
Currency
IDR
Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Indonesia
Country code
ID
Employees
2,908
Employees Change
-54%
Employees Change Percent
-1.82
Enterprise value
IDR 1.5T
Exchange
Indonesia Stock Exchange
Financial currency
IDR
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
ID1000138001
Last refreshed
2026-05-10
Market cap
IDR 2.3T
Price
IDR 2,530
Price currency
IDR
Rev Per Employee
790,945,667.13x
Sector
Healthcare
Sic
8071
Symbol
idx/PRDA
Website
https://prodia.co.id/id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
9.64%
EV Earnings
6.9x
EV/EBIT
6.06x
EV/EBITDA
3.52x
EV/FCF
4.06x
EV/Sales
0.65x
FCF yield
16.39%
Forward P/E
8.84x
P/B ratio
0.93x
P/E ratio
10.46x
P/S ratio
0.98x
PE Ratio10 Y
17.41x
PE Ratio3 Y
13.22x
PE Ratio5 Y
12.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
10.54%
EBITDA Margin
15.07%
FCF margin
16.05%
Gross margin
57.57%
Gross Profit
IDR 1.3T
Gross Profit Growth
0.86%
Gross Profit Growth Q
3.27%
Gross Profit Growth3 Y
1.51%
Gross Profit Growth5 Y
1.78%
Net Income
IDR 217.1B
Net Income Growth
-8.8%
Net Income Growth Q
149.44%
Net Income Growth Quarters
2%
Net Income Growth Years
0%
Net Income Growth3 Y
-13.7%
Net Income Growth5 Y
-11.18%
Pretax Margin
12.12%
Profit Margin
9.44%
Profit Per Employee
IDR 74.7M
Profitable Years
13
ROA
5.53
Roa5y
9.67
ROCE
9.63
ROE
8.84
Roe5y
15.44
ROIC
11.39
Roic5y
31.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr1y
8.09%
Cagr3y
-16.95%
Cagr5y
-5.34%
Div CAGR3
-11.89%
Div CAGR5
-1.11%
EPS Growth
-4.79
EPS Growth Q
162.8
EPS Growth Quarters
2
EPS Growth Years
0
EPS Growth3 Y
-12.38
EPS Growth5 Y
-10.1
FCF Growth
20.08%
FCF Growth Q
11.67%
FCF Growth3 Y
0.47%
FCF Growth5 Y
3.55%
OCF Growth
1.22%
OCF Growth Q
12.63%
OCF Growth10 Y
9.94%
OCF Growth3 Y
-7.41%
OCF Growth5 Y
-0.23%
Revenue Growth
2.3x
Revenue Growth Q
3.8x
Revenue Growth Quarters
2x
Revenue Growth Years
3x
Revenue Growth3 Y
2.38x
Revenue Growth5 Y
1.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
IDR 0.84
Assets
IDR 2.7T
Cash
IDR 772.2B
Current Assets
IDR 1T
Current Liabilities
IDR 157.3B
Debt
IDR 17.3B
Debt EBITDA
IDR 0.04
Debt Equity
IDR 0.01
Debt FCF
IDR 0.05
Equity
IDR 2.4T
Interest Coverage
140.7
Liabilities
IDR 263.5B
Long Term Assets
IDR 1.7T
Long Term Liabilities
IDR 106.2B
Net Cash
IDR 754.9B
Net Cash By Market Cap
IDR 33.53
Net Cash Growth
-6.18%
Net Debt EBITDA
IDR -2.18
Net Debt Equity
IDR -0.31
Net Debt FCF
IDR -2.05
Tangible Book Value
IDR 2.2T
Tangible Book Value Per Share
IDR 2,435
WACC
2.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.44
Inventory Turnover
23.84
Net Working Capital
IDR 91.3B
Quick ratio
5.89
Working Capital
IDR 855.8B
Working Capital Turnover
IDR 2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
4.21%
Dividend Growth
-5.92%
Dividend Growth Years
1%
Dividend per share
IDR 173
Dividend Years
10
Dividend Yield
6.84%
Ex Div Date
2026-05-05
Last Dividend
IDR 163
Payout Frequency
Annual
Payout Ratio
74.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
8.08%
200-day SMA
2,552.2
3Y total return
-42.72%
50-day SMA
2,486.2
50-day SMA vs 200-day SMA
50under200
5Y total return
-24%
All Time High
10,000
All Time High Change
-74.7%
All Time High Date
2021-12-14
All Time Low
1,995
All Time Low Change
26.82%
All Time Low Date
2018-11-22
ATR
71.17
Beta
-0.3
Beta1y
-0.06
Beta2y
0.13
Ch YTD
10
High
2,530
High52
3,010
High52 Date
2025-08-07
High52ch
-15.95%
Low
2,440
Low52
2,290
Low52 Date
2025-12-30
Low52ch
10.48%
Ma50ch
1.76%
Price vs 200-day SMA
-0.87%
RSI
52.45
RSI Monthly
38.19
RSI Weekly
54.37
Sharpe ratio
0.44x
Sortino ratio
1.03
Total Return
11.04%
Tr YTD
17.34
Tr1m
8.83%
Tr1w
3.8%
Tr3m
12.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
IDR 242.4B
Operating Income Growth
-4.41
Operating Income Growth3 Y
-15.47
Operating Income Growth5 Y
-12.25
Operating margin
10.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
242,900,100%
Net Borrowing
-43,128,000,000
Shares Insiders
0%
Shares Institutions
1.66%
Shares Out
889,775,500
Shares Qo Q
-2.22%
Shares Yo Y
-4.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
IDR 369.1B
Average Volume
357,760x
Bv Per Share
2,707.9
CAPEX
IDR -67.6B
Ch1m
2.02
Ch1w
-2.69
Ch1y
-5.24
Ch3m
5.86
Ch3y
-52.26
Ch5y
-42.5
Ch6m
-1.17
Change
3.27%
Change From Open
3.27
Close
2,450
Days Gap
0
Depreciation Amortization
104,279,000,000
Dollar Volume
2,374,658,000
Earnings Date
2026-05-13
EBIT
IDR 242.4B
EBITDA
IDR 346.7B
EPS
IDR 242
F Score
7
FCF
IDR 369.1B
FCF EV Yield
24.63x
FCF Per Share
IDR 415
Financing CF
-339,337,000,000
Fiscal Year End
December
Founded
1,973
Graham Number
3837.97101
Graham Upside
51.7
Income Tax
IDR 61.8B
Investing CF
49,698,000,000
Is Primary Listing
1
Last Earnings Date
2025-10-31
Last Report Date
2026-03-31
Lynch Fair Value
IDR 1,209
Lynch Upside
-52.22
Ma150
2,466.7
Ma150ch
2.57%
Ma20
2,509
Ma20ch
0.84%
Net CF
147,062,000,000
Next Earnings Date
2026-05-13
Open
2,450
P FCF Ratio
6.1
P OCF Ratio
5.15
Payment Date
2026-05-22
Position In Range
100
Ppne
1,004,116,000,000
Price Date
2026-05-08
Price EBITDA
IDR 6.49
Ptbv Ratio
1.04
Relative Volume
2.79x
Revenue
2,300,070,000,000x
Tax By Revenue
2.69x
Tax Rate
22.16%
Tr6m
5.43%
Volume
938,600
Z Score
7.65
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

IDX/PRDA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+6.8%
$173 annual per share
Payout ratio
+74.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-1.1%
1 consecutive years of growth
Total shareholder yield
+11.0%
Next ex-dividend date: 2026-05-05
Performance

IDX/PRDA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+8.1%
S&P 500 1Y: n/a
3Y total return
-42.7%
S&P 500 3Y: n/a
5Y total return
-24.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns IDX/PRDA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.7%
Share of float held by funds and institutions
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-4.2%
Negative means the company is buying back shares.
Technical

IDX/PRDA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.4
Neutral momentum band
Price vs 200-day MA
-0.9%
50/200-day relationship not available
Beta (5Y)
-0.30
Less volatile than the market
Sharpe ratio
0.44
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IDX/PRDA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/PRDA stock rating?

idx/PRDA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/PRDA analysis?

The full report lives at /stocks/idx/PRDA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/PRDA?

The latest report frames idx/PRDA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/PRDA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.